Your browser doesn't support javascript.
loading
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial.
Llop-Guevara, A; Loibl, S; Villacampa, G; Vladimirova, V; Schneeweiss, A; Karn, T; Zahm, D-M; Herencia-Ropero, A; Jank, P; van Mackelenbergh, M; Fasching, P A; Marmé, F; Stickeler, E; Schem, C; Dienstmann, R; Florian, S; Nekljudova, V; Balmaña, J; Hahnen, E; Denkert, C; Serra, V.
Affiliation
  • Llop-Guevara A; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Loibl S; GBG, Medicine and Research, Neu-Isenburg, Germany.
  • Villacampa G; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Vladimirova V; GBG, Medicine and Research, Neu-Isenburg, Germany.
  • Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Universitätsklinikum und Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Karn T; Goethe University Hospital, Frankfurt, Germany.
  • Zahm DM; SRH Wald-Klinikum Gera, Gera, Germany.
  • Herencia-Ropero A; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Jank P; Institut für Pathologie, UKGM Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • van Mackelenbergh M; Universitätsklinikum Schleswig-Holstein, Klinik für Gynäkologie und Geburtshilfe, Schleswig-Holstein, Kiel, Germany.
  • Fasching PA; Universitätsklinikum Erlangen, Erlangen, Germany.
  • Marmé F; Medizinische Fakultät Mannheim, Universität Heidelberg, Universitätsfrauenklinik Mannheim, Mannheim, Germany.
  • Stickeler E; Klinik für Gynäkologie, Uniklinik RWTH Aachen, Aachen, Germany.
  • Schem C; Mammazentrum Hamburg, Hamburg, Germany.
  • Dienstmann R; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Florian S; Institut für Pathologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Nekljudova V; GBG, Medicine and Research, Neu-Isenburg, Germany.
  • Balmaña J; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Hahnen E; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
  • Denkert C; Institut für Pathologie, UKGM Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Serra V; Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: vserra@vhio.net.
Ann Oncol ; 32(12): 1590-1596, 2021 12.
Article in En | MEDLINE | ID: mdl-34520831
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: